MyFinsight
Home
Blog
About
Back
Income Statement
CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX)
source: myfinsight.com
Total comprehensive
income (loss)
-$20,964K
(-17370.00%↓ Y/Y)
Net income (loss)
attributable to common...
-$20,666K
Unrealized gain (loss) on
investments, net of tax
-$298K
(-976.47%↓ Y/Y)
Income (loss) before
income taxes
-$20,606K
(-22543.96%↓ Y/Y)
Provision for income taxes
$60K
(-4.76%↓ Y/Y)
Interest income
$3,157K
(168.00%↑ Y/Y)
Other income
$18K
(5.88%↑ Y/Y)
Income (loss) from
operations
-$23,781K
(-1749.22%↓ Y/Y)
Revenues
$1,418K
(-92.40%↓ Y/Y)
Total operating
expenses
$25,199K
(26.35%↑ Y/Y)
Research and development
$17,598K
(32.10%↑ Y/Y)
General and
administrative
$7,601K
(14.78%↑ Y/Y)
Back